HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of sirolimus for epileptic seizures in childhood associated with focal cortical dysplasia type II.

AbstractOBJECTIVE:
The efficacy of the mechanistic target of rapamycin inhibitor, sirolimus, was recently reported for patients more than 6 years of age by Kato et al. We evaluated the efficacy and safety of sirolimus in a 2-year-old patient with recurrent focal seizures with impaired consciousness after focal cortical dysplasia (FCD) type IIa resection.
METHODS:
The patient was a 2-year-old girl who had recurrent seizures after undergoing FCD resection at 4 months of age. The initial dose of sirolimus was 0.5 mg/day and was gradually increased using the trough blood concentration before oral administration as an index, and evaluation was performed at 92 weeks.
RESULTS:
The trough blood level of sirolimus was increased to 6.1 ng/mL and maintenance therapy was started at 40 weeks. Focal seizures with impairment of consciousness with tonic extension of the limbs decreased. No critically serious adverse events occurred.
CONCLUSION:
Sirolimus was effective against epileptic seizures from FCD type II even for a child under 5 years of age. There were no critically serious adverse events and administration could be continued.
AuthorsHideaki Shiraishi, Tsuyoshi Teramoto, Saki Yokoshiki, Jun Tohyama, Yuki Ueda, Kiyoshi Egawa, Norihiro Sato, Atsushi Manabe, Mitsuhiro Kato
JournalBrain & development (Brain Dev) Vol. 45 Issue 6 Pg. 343-347 (Jun 2023) ISSN: 1872-7131 [Electronic] Netherlands
PMID36870920 (Publication Type: Case Reports)
CopyrightCopyright © 2023 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Sirolimus
Topics
  • Child
  • Female
  • Humans
  • Child, Preschool
  • Sirolimus (therapeutic use, pharmacology)
  • Focal Cortical Dysplasia
  • Seizures (drug therapy, etiology, surgery)
  • Epilepsy (drug therapy, etiology, surgery)
  • Epilepsy, Generalized
  • Malformations of Cortical Development (complications, drug therapy)
  • Magnetic Resonance Imaging

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: